A compound of Formula wherein R 1, R 2 and R 3 are independently selected from hydrogen, C 1 -C 3 haloalkyl and C 1 -C 3 alkyl; A represents wherein X represents CH 2, S, SO, SO 2, NR 5, NCOR 5, NCOR 9, NCOCH 2 R 9, O, or a bond; Y represents N, CH or C; n is selected from 1, 2, 3 and 4; R 4 is selected from hydrogen, halogen, COR 6, C 1 -C 6 alkyl, C 1 -C 3 alkoxyC 1 -C 3 alkyl, C 1 -C 6 alkoxy, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocyclyl, C 1 -C 3 cyanoalkyl, C 1 -C 3 haloalkyl, aryl and heteroaryl, wherein said aryl and said heteroaryl are optionally substituted with one or more R 7; R 5 is selected from hydrogen, C 1 -C 3 fluoroalkyl, C 1 -C 3 alkyl, C 1 -C 3 alkoxyC 1 -C 3 alkyl and C 3 -C 6 cycloalkyl; R 6 is selected from C 1 -C 3 alkoxy, N-C 1 -C 3 alkylamino, N,N-diC 1 -C 3 alkylamino, 1-pyrrolidinyl, 1-piperidinyl and 1-azetidinyl; R 7 is selected from C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 3 alkoxyC 1 -C 3 alkyl, C 1 -C 3 haloalkyl, halogen, N-C 1 -C 3 alkylamino, N,N-diC 1 -C 3 alkylamino, C 1 -C 3 haloalkoxy and C 1 -C 3 alkoxy; R 9 is selected from C 1 -C 3 alkyl, C 1 -C 3 alkoxy, C 3 -C 6 cycloalkyl, heterocyclyl, phenyl and a monocyclic heteroaryl, wherein said heterocyclyl, said phenyl and said monocyclic heteroaryl are optionally substituted with one or two R 8; R 8 is selected from halogen, C 1 -C 3 haloalkyl and C 1 -C 3 alkyl; and pharmaceutically acceptable salts, stereoisomers and tautomers thereof. R 1, R 2 and R 3 are independently selected from hydrogen, C 1 -C 3 haloalkyl and C 1 -C 3 alkyl; A represents wherein X represents CH 2, S, SO, SO 2, NR 5, NCOR 5, NCOR 9, NCOCH 2 R 9, O, or a bond; Y represents N, CH or C; n is selected from 1, 2, 3 and 4; R 4 is selected from hydrogen, halogen, COR 6, C 1 -C 6 alkyl, C 1 -C 3 alkoxyC 1 -C 3 alkyl, C 1 -C 6 alkoxy, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocyclyl, C 1 -C 3 cyanoalkyl, C 1 -C 3 haloalkyl, aryl and heteroaryl, wherein said aryl and said heteroaryl are optionally substituted with one or more R 7; R 5 is selected from hydrogen, C 1 -C 3 fluoroalkyl, C 1 -C 3 alkyl, C 1 -C 3 alkoxyC 1 -C 3 alkyl and C 3 -C 6 cycloalkyl; R 6 is selected from C 1 -C 3 alkoxy, N-C 1 -C 3 alkylamino, N,N-diC 1 -C 3 alkylamino, 1-pyrrolidinyl, 1-piperidinyl and 1-azetidinyl; R 7 is selected from C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 3 alkoxyC 1 -C 3 alkyl, C 1 -C 3 haloalkyl, halogen, N-C 1 -C 3 alkylamino, N,N-diC 1 -C 3 alkylamino, C 1 -C 3 haloalkoxy and C 1 -C 3 alkoxy; R 9 is selected from C 1 -C 3 alkyl, C 1 -C 3 alkoxy, C 3 -C 6 cycloalkyl, heterocyclyl, phenyl and a monocyclic heteroaryl, wherein said heterocyclyl, said phenyl and said monocyclic heteroaryl are optionally substituted with one or two R 8; R 8 is selected from halogen, C 1 -C 3 haloalkyl and C 1 -C 3 alkyl; and pharmaceutically acceptable salts, stereoisomers and tautomers thereof. X represents CH 2, S, SO, SO 2, NR 5, NCOR 5, NCOR 9, NCOCH 2 R 9, O, or a bond; Y represents N, CH or C; n is selected from 1, 2, 3 and 4; R 4 is selected from hydrogen, halogen, COR 6, C 1 -C 6 alkyl, C 1 -C 3 alkoxyC 1 -C 3 alkyl, C 1 -C 6 alkoxy, C 3 -C 6 cycloalkyl, C 3 -C 6 heterocyclyl, C 1 -C 3 cyanoalkyl, C 1 -C 3 haloalkyl, aryl and heteroaryl, wherein said aryl and said heteroaryl are optionally substituted with one or more R 7; R 5 is selected from hydrogen, C 1 -C 3 fluoroalkyl, C 1 -C 3 alkyl, C 1 -C 3 alkoxyC 1 -C 3 alkyl and C 3 -C 6 cycloalkyl; R 6 is selected from C 1 -C 3 alkoxy, N-C 1 -C 3 alkylamino, N,N-diC 1 -C 3 alkylamino, 1-pyrrolidinyl, 1-piperidinyl and 1-azetidinyl; R 7 is selected from C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl, C 1 -C 3 alkoxyC 1 -C 3 alkyl, C 1 -C 3 haloalkyl, halogen, N-C 1 -C 3 alkylamino, N,N-diC 1 -C 3 alkylamino, C 1 -C 3 haloalkoxy and C 1 -C 3 alkoxy; R 9 is selected from C 1 -C 3 alkyl, C 1 -C 3 alkoxy, C 3 -C 6 cycloalkyl, heterocyclyl, phenyl and a monocyclic heteroaryl, wherein said heterocyclyl, said phenyl and said monocyclic heteroaryl are optionally substituted with one or two R 8; R 8 is selected from halogen, C 1 -C 3 haloalkyl and C 1 -C 3 alkyl; and pharmaceutically acceptable salts, stereoisomers and tautomers thereof.